throbber
Top 50 pharmaceutical products by global sales - Top Pharma List - PMLiVE
`
`PME
`
`Communiqué
`
`To help make this website better we have placed cookies on your computer. You can change your cookie settings at any time. Otherwise, we'll
`assume you're OK to continue. REMOVE THIS MESSAGE
`The Directory
`Quality in Care
`How to Advertise
`
`Privacy and cookies
`
`My Account
`
`Register
`
`Home
`
`News
`
`Intelligence
`
`Thought leadership
`
`Appointments
`
`Awards
`
`Blogs
`
`Clinical
`
`Top Pharma List
`
`PMHub
`
`
`
`
`
`
`
`Advanced search
`Jobs
`
`Metabolic
`Immunology
`CNS
`Cardiovascular
`Biologic
`Japan
`US
`Global
`Top Pharma List
`Trending Novartis' Cosentyx 'outpacing competitors' Communiqué 2016 finalists revealed AZ sells Zurampic rights to Gruenenthal
`
`Infographic
`Products
`Oncology
`Lilly planning 20 new launches
`
`Data by
`
`Featured jobs
`
`Top 50 pharmaceutical products by global sales
`The rankings of the top 50 pharmaceutical products have been compiled from GlobalData's
`pharmaceutical revenue figures. The rankings include figures for 2014, 2013, 2012 and 2011.
`
`The PMLiVE Top Pharma List also features rankings of the 25 biggest pharmaceutical
`companies, based on their annual, global sales.
`
`2014
`
`2013
`
`2012
`
`#
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`Product
`
`Humira
`
`Sovaldi/Harvoni
`
`Remicade
`
`Enbrel
`
`Lantus
`
`MabThera/Rituxan
`
`Avastin
`
`2014 ($m)
`
`2013 ($m)
`
`Growth ($m)
`
`Growth (%)
`
`13021
`
`12410
`
`10151
`
`9120
`
`8152
`
`7356
`
`6841
`
`6700
`
`11105
`
`139
`
`9900
`
`8894
`
`7343
`
`7410
`
`6667
`
`8356
`
`1916
`
`12271
`
`251
`
`226
`
`809
`
`-54
`
`174
`
`-1656
`
`17
`
`8828
`
`3
`
`3
`
`11
`
`-1
`
`3
`
`-20
`
`Principal Medical Writer – Medical
`Education Agency - Home Based...
`Salary TBC
`
`Medical Copywriter, Healthcare Advertising
`
`Senior Medical Writer
`Great salary and benefits
`Account Manager, Healthcare PR
`£ 35, 000 - £45, 000 benefits
`Account Manager, Healthcare Advertising Agency
`£28, 000-£32, 000
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`Seretide/Advair
`
`Herceptin
`
`Crestor
`
`Abilify
`
`Lyrica
`
`Revlimid
`
`Gleevec/Glivec
`
`Spiriva
`
`Neulasta
`
`Prevnar 13
`
`Nexium
`
`Symbicort
`
`Lucentis
`
`6690
`
`6617
`
`6416
`
`5435
`
`4980
`
`4746
`
`4722
`
`4596
`
`4464
`
`4442
`
`4262
`
`4254
`
`6481
`
`6960
`
`9502
`
`4838
`
`4280
`
`4693
`
`4564
`
`4392
`
`3974
`
`4551
`
`3929
`
`4184
`
`209
`
`-343
`
`-3086
`
`597
`
`700
`
`53
`
`158
`
`204
`
`490
`
`-109
`
`333
`
`70
`
`3
`
`-5
`
`-32
`
`12
`
`16
`
`1
`
`3
`
`5
`
`12
`
`-2
`
`8
`
`2
`
`http://www.pmlive.com/top_pharma_list/Top_50_pharmaceutical_products_by_global_sales#[6/30/2016 1:41:11 PM]
`
`Subscribe to our email news alerts
`
`Most read
`
`Most shared
`
`Latest content
`
`Sanofi and Boehringer agree asset swap deal
`
`UK pharma faces 'immediate challenges' following
`Brexit
`
`IBM plans Watson-powered 'diabetes advisor'
`
`Integrated thinking - it’s both art and science
`
`The Digital Patient
`
`Diabetes UK uses Lego to address diabetes myths
`
`MYLAN PHARMS. INC. EXHIBIT 1055 PAGE 1
`
`

`
`Top 50 pharmaceutical products by global sales - Top Pharma List - PMLiVE
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Copaxone
`
`Januvia
`
`Xarelto
`
`Truvada
`
`Atripla
`
`Olmesartan franchise
`
`Eylea
`
`Avonex
`
`4237
`
`3931
`
`3679
`
`3528
`
`3470
`
`3187
`
`3034
`
`3013
`
`4328
`
`4004
`
`2083
`
`3304
`
`3649
`
`3761
`
`2072
`
`3006
`
`-91
`
`-73
`
`1596
`
`224
`
`-179
`
`-574
`
`962
`
`7
`
`-2
`
`-2
`
`77
`
`7
`
`-5
`
`-15
`
`46
`
`0
`
`PMHub
`
`Add my company
`
`Any category...
`
`29
`
`30
`
`31
`
`32
`
`33
`
`34
`
`35
`
`36
`
`NovoRapid
`
`Gilenya
`
`Tecfidera
`
`Velcade
`
`Zetia
`
`Alimta
`
`Humalog
`
`Lipitor
`
`3012
`
`2934
`
`2909
`
`2881
`
`2866
`
`2792
`
`2785
`
`2766
`
`2908
`
`2337
`
`876
`
`2852
`
`2879
`
`2703
`
`2611
`
`3097
`
`104
`
`597
`
`2033
`
`29
`
`-13
`
`89
`
`174
`
`-331
`
`4
`
`26
`
`232
`
`1
`
`0
`
`3
`
`7
`
`-11
`
`-8
`
`E-lixir Consulting
`E-lixir offers digital
`solutions and consulting for
`events and trainings. We
`design the most
`customised applications for
`congresses, events, sales...
`
`Latest intelligence
`
`How to conduct a pharma content audit
`A pharma content audit is essential for identifying
`whether your site delivers comprehensive, valuable
`information for the purpose of meeting the needs of your
`content marketing efforts....
`
`37
`
`38
`
`39
`
`40
`
`41
`
`42
`
`43
`
`44
`
`Celebrex
`
`Plavix
`
`Levemir
`
`Rebif
`
`Diovan/Co-Diovan
`
`Victoza
`
`Olysio
`
`Cialis
`
`2699
`
`2601
`
`2454
`
`2364
`
`2345
`
`2318
`
`2302
`
`2291
`
`2918
`
`2644
`
`1993
`
`2396
`
`3524
`
`2008
`
`23
`
`2159
`
`2204
`
`-219
`
`-43
`
`461
`
`-32
`
`-1179
`
`310
`
`2279
`
`132
`
`53
`
`-2
`
`23
`
`-1
`
`-33
`
`15
`
`9909
`
`6
`
`2
`
`Do your customers feel
`that you’re listening to
`them?
`When answering to data,
`excellent digital communication can create much
`stronger relationships between reps and customers....
`
`Mapping content strategies to pharma
`lifecycle management
`In these tough economic times, we should be ramping
`up our pharma lifecycle management (LCM) strategies.
`These are well-established strategies for managing and
`extending the commercial value of products. So...
`
`45
`
`46
`
`47
`
`48
`
`49
`
`50
`
`Erbitux
`
`Prograf
`
`Zytiga
`
`Soliris
`
`Botox/Neuromodulator
`
`Lovenox
`
`2257
`
`2249
`
`2237
`
`2234
`
`2231
`
`2183
`
`2273
`
`1698
`
`1551
`
`1982
`
`2188
`
`-24
`
`539
`
`683
`
`249
`
`-5
`
`-1
`
`32
`
`44
`
`13
`
`0
`
`Note: The 2013 ranking uses 2013 exchange rates for both its 2013 and 2012 values, to remove the effect of currency
`fluctuations. The 2012 ranking similarly uses 2012 exchange rates.
`
` Data by GlobalData
`GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries.
`With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate
`and transparent industry insight that helps our clients to achieve growth and increase business value.
`
`To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
`
`Quick links
`
`Country reports
`
`HTA guidance tracker
`
`Orphan drugs and rare
`diseases
`
`PME supplements
`
`Social media hub
`
`Webinars
`
`Digital Handbook
`
`The Gallery
`
`Healthcare glossary
`
`How to advertise
`
`Infographics
`
`http://www.pmlive.com/top_pharma_list/Top_50_pharmaceutical_products_by_global_sales#[6/30/2016 1:41:11 PM]
`
`Multimedia
`
`Webinar: Customer engagement design
`
`MYLAN PHARMS. INC. EXHIBIT 1055 PAGE 2
`
`

`
`Top 50 pharmaceutical products by global sales - Top Pharma List - PMLiVE
`
`About us Contact us How to advertise Site map All content copyright © PMGroup Worldwide Ltd 2016
`
`http://www.pmlive.com/top_pharma_list/Top_50_pharmaceutical_products_by_global_sales#[6/30/2016 1:41:11 PM]
`
`MYLAN PHARMS. INC. EXHIBIT 1055 PAGE 3

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket